I am invested as a long term investor in several ASX biotech companies which in their own right have some impressive products going through the long trial and approval process.
For me, NEU is such a wonderful company to be involved with as a shareholder.
Trof / Daybue a drug that truly changes the lives of young sufferers, their families and carers.
I couldn't be more delighted in my investment and the difference NEU is making.
I have investments in several companies involved with developing drugs for the treatment of various forms of cancer.
Such a complex area and a long journey to prove your drug is more safe & effective that other competing drugs.
NEU seems to be in a complex field of its own.
And 2591 is likely to provide much hope to unfortunate suffers of 100+ highly debilitating neurodevelopmental disorders.
What a company / what a team!!!
Well done NEU.
GLTA
Daybue Rollout, page-50
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.57 |
Change
2.170(15.1%) |
Mkt cap ! $2.117B | |||
| Open | High | Low | Value | Volume |
| $14.85 | $16.67 | $14.60 | $24.77M | 1.544M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1500 | $16.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.57 | 1717 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |